
Ari M. Melnick
58_edit.jpg

Contact Information
Ari M. Melnick
Expertise
Biology of the immune system; lymphomas and leukemias; epigenetics; cancer experimental therapeutics
Current Research Interest
Mechanisms through which the epigenome programs the normal immune response; how mutations in epigenetic modifier genes causes lymphoma; the molecular epigenetic blueprints that determine the biology of acute leukemias; novel therapeutic agents and regimens for patients with lymphomas and leukemias
Distinction
Sidney Kimmel Foundation Scholar in Cancer Research
Leukemia and Lymphoma Society Scholar
American Society of Hematology Scholar Award
Burroughs Wellcome Fund Clinical Scientist Award in Translational Research
American Society of Clinical Investigation
Association of American Physicians
Selected Publications
Duy Cihangir, Matt Teater, Francine E. Garrett-Bakelman, Tak C. Lee, Cem Meydan, Jacob L. Glass, Meng Li, et al.”Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML.” Cancer Discovery (2019).
Hatzi, Katerina, Huimin Geng, Ashley S. Doane, Cem Meydan, Reed LaRiviere, Mariano Cardenas, Cihangir Duy, et al. “Histone Demethylase LSD1 is Required for Germinal Center Formation and BCL6-Driven Lymphomagenesis.” Nature Immunology 20 (2019): 86-96.